Processing your payment...
Please do not close your browser.

PEGylated Proteins Market Growth, Trends and Forecast (2022-2029) By Type (Colony Stimulating Factor, Interferon, Erythropoietin (EPO)) By Application (Cancer, Autoimmune Disease, Hepatitis, Multiple Sclerosis) and By Regions

12 Jul, 2022 | 139 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Over the forecast period, the PEGylated Proteins Market will register a CAGR 9.9 % in terms of revenue and the global market size will reach USD 1.7 Billion by 2029.

PEGylated Proteins Market Overview

PEGylation is the process of attaching polyethylene glycol polymer chains to molecules, such as medication, therapeutic protein, or vesicle, covalently and non-covalently. The market for PEGylated Protein Therapeutics is anticipated to develop significantly over the projected period, primarily as a result of rising PEGylation demand, an increase in the prevalence of chronic illnesses, and the existence of potent new treatment candidates. PEGylated compounds also have certain additional benefits that contribute to the market expansion, including increased proteolytic protection, a longer half-life, lower toxicity, and decreased immunogenicity. On the other hand, increased PEGylation process costs and the patent expiration of some medications are anticipated to restrain market expansion.

The major market drivers include an increase in pharmaceutical and biotechnology companies' R&D expenditures, expansion in the biologics industry, a rise in the use of protein-based drugs over non-protein-based medicines, and an improvement in protein stability and circulating half-life through PEGylation. On the other hand, the primary issue impeding the expansion of this industry is medication failure and recalls.

What is our PEGylated Proteins Market report scope?

 

Report Attributes

 

 

Report Details

 

Forecast Period 2022 to 2029

 

CAGR of 9.9 % during the review period (2022 to 2029).

 

By Type

  • Colony Stimulating Factor
  • Interferon
  • Erythropoietin (EPO)
  • Recombinant Factor VIII
  • Monoclonal Antibody
  • Enzyme
  • Others

 

By Application

 

 

 

 

  • Cancer
  • Autoimmune Disease
  • Hepatitis
  • Multiple Sclerosis
  • Hemophilia
  • Gastrointestinal Disorder
  • Others

 

 

 

By Companies

  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • NOF America Corporation
  • JenKem Technology USA Inc.
  • Creative PEGworks
  • Celares GmbH
  • Others

 

 

 

Regions Covered

 

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

 

 

 

 

 

 

 

Countries Covered

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America

Base Year

2022

 

Historical Year

 

 

2017 to 2021

Forecast Year

 

2022 to 2029

Number of Pages

139

 

Customization Available

 

 

Yes, the report can be customized as per your needs

Frequently Asked Questions

What is the current Market size and compound annual growth rate (CAGR) of the PEGylated Proteins Market during the forecast period (2022-2029)?

The PEGylated Proteins Market is growing at a CAGR of 9.9 % over the next 7 years.

Who are the key players in PEGylated Proteins Market?

Merck KGaA, Thermo Fisher Scientific Inc., NOF America Corporation, JenKem Technology USA Inc., Creative PEGworks, and Celares GmbH, Others.

What region does this PEGylated Proteins Market report covers?

North America (the United States, Canada, and Mexico), Europe (Germany, France, UK, Russia, and Italy), Asia-Pacific (China, Japan, Korea, India, and Southeast Asia), South America (Brazil, Argentina, Colombia, etc.), The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

What are the significant Type of PEGylated Proteins Market?

Colony Stimulating Factor, Interferon, Erythropoietin (EPO), Recombinant Factor VIII, Monoclonal Antibody, Enzyme, and Others.

What are the significant Application of PEGylated Proteins Market?

Cancer, Autoimmune Disease, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorder, and Others.

Who are the Major Players in PEGylated Proteins Market?

Market Growth Reports lists out all the PEGylated Proteins Market companies that are presently striving to reduce the impact of the Covid-19 pandemic on the Market- Merck KGaA, Thermo Fisher Scientific Inc., NOF America Corporation, JenKem Technology USA Inc., Creative PEGworks, and Celares GmbH, Others.

Industry News:

In August 2021, JenKem Technology, PEG derivatives for Lipid Nanoparticles (LNPs), and related PEG intermediates are produced on a large scale according to GMP.

What are the major Types and Applications for PEGylated Proteins Market?

By Type, it is segmented into

  • Colony Stimulating Factor
  • Interferon
  • Erythropoietin (EPO)
  • Recombinant Factor VIII
  • Monoclonal Antibody
  • Enzyme
  • Others

By Application, it is segmented into

  • Cancer
  • Autoimmune Disease
  • Hepatitis
  • Multiple Sclerosis
  • Hemophilia
  • Gastrointestinal Disorder
  • Others

PEGylated Proteins Market Regional Analysis

Throughout the whole forecast period, North America is anticipated to lead the global PEGylated protein market. Some of the main factors responsible for its significant market share are the existence of important companies, the high incidence of chronic diseases in the area, the developed healthcare infrastructure, and the rising awareness of cutting-edge treatment choices among Americans. The United States now has the greatest market share in North America, and because of the size of its patient population, this area is expected to have increased demand. Nearly 2,281,658 cancer cases were identified in 2020, and the disease was responsible for 612,390 fatalities in the country.

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East & Africa
    • Latin America
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
  4. Key Insights
    1. Pricing Analysis, By Key Regions, 2022
    2. Price Comparison (USD Per Ton) By Type (Colony Stimulating Factor, Interferon, Erythropoietin (EPO), Recombinant Factor VIII, Monoclonal Antibody, Enzyme, and Others) 2022
    3. Price Comparison (USD, Per Ton): By Application (Cancer, Autoimmune Disease, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorder, and Others) 2022
    4. Impact of COVID-19 on the PEGylated Proteins Market
    5. Production Share of PEGylated Proteins, By Region, 2022
    6. Key Industry Developments
  5. Global PEGylated Proteins Market Analysis, Insights and Forecast, 2022-2029
    1. Market Analysis, Insights, and Forecast – By Type
      1. Colony Stimulating Factor
      2. Interferon
      3. Erythropoietin (EPO)
      4. Recombinant Factor VIII
      5. Monoclonal Antibody
      6. Enzyme
      7. Others 
    2. Market Analysis, Insights, and Forecast – By Application
      1. Cancer
      2. Autoimmune Disease
      3. Hepatitis
      4. Multiple Sclerosis
      5. Hemophilia
      6. Gastrointestinal Disorder
      7. Others 
    3. Market Analysis, Insights, and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of World
  6. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Products, SWOT analysis, recent developments, strategies, financials (based on availability))
      1. Merck KGaA
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Thermo Fisher Scientific Inc.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. NOF America Corporation
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. JenKem Technology USA Inc.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)

 

 

 

 

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Request A Sample

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Korean Institute of Tuberculosis
  • Sanyo chemical Industries LTD
  • Novartis
  • Hisamitsu
  • Pfizer
  • AbbVie
  • RevHealth
  • Zeon Corporation
  • Abbott (Established Pharmaceutical Products)
  • Sinopharm (pharmaceutical distribution segment)
  • Takeda Pharmaceutical
  • Gilead Sciences
  • Sartorius
  • Zavation
  • Permobil
  • Ansell
  • Cefla